PKD - Initiation of Multiple Dose Clinical Trial
Filed with ASX · · 3 pages · English
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Presentation of Ophthalmology Clinical Trial Data at ARVO
- ADOA Program - SRC Approve Progression to Multi-Dose Study
- Completion of Retail Entitlement Offer
- PKD Clinical Trial - Approval to Escalate Dosing
- Half Yearly Report and Accounts
Later from PYC Therapeutics
- ADOA Program Update
- PKD - Safety Committee Approves Dose Escalation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notification regarding unquoted securities - PYC
- Change of Director's Interest Notice
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics